Are the triptans for migraine therapy worth the cost?

Authors
Becker, WJ
Citation
Wj. Becker, Are the triptans for migraine therapy worth the cost?, CAN J NEUR, 27(2), 2000, pp. 111-115
Citations number
24
Categorie Soggetti
Neurology,"Neurosciences & Behavoir
Journal title
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
ISSN journal
03171671 → ACNP
Volume
27
Issue
2
Year of publication
2000
Pages
111 - 115
Database
ISI
SICI code
0317-1671(200005)27:2<111:ATTFMT>2.0.ZU;2-J
Abstract
The triptans represent a major advance in migraine therapy but their cost p er dose greatly exceeds that of many older treatments. There is evidence th at for a significant proportion of migraine patients these new drugs can sh ow a positive cost benefit and also improve quality of life. Cost benefit w ould be expected to be greatest in patients with more severe migraine attac ks.